Skip to main content
Veterinary Medicines

NEOSKILAB Solution for injection

Authorised
  • NEOSTIGMINE METHYLSULFATE

Product identification

Medicine name:
NEOSKILAB Solution for injection
NEOSKILAB 1,5 mg/ml šķīdums injekcijām liellopiem, aitām, kazām un zirgiem
Active substance:
  • NEOSTIGMINE METHYLSULFATE
Target species:
  • Cattle
  • Sheep
  • Goat
  • Horse
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • NEOSTIGMINE METHYLSULFATE
    1.50
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        no withdrawal period
      • Milk
        no withdrawal period
    • Sheep
      • Meat and offal
        no withdrawal period
      • Milk
        no withdrawal period
    • Goat
      • Meat and offal
        no withdrawal period
      • Milk
        no withdrawal period
    • Horse
      • Meat and offal
        no withdrawal period
      • Milk
        no withdrawal period
  • Subcutaneous use
    • Cattle
      • Meat and offal
        no withdrawal period
      • Milk
        no withdrawal period
    • Sheep
      • Meat and offal
        no withdrawal period
      • Milk
        no withdrawal period
    • Goat
      • Meat and offal
        no withdrawal period
      • Milk
        no withdrawal period
    • Horse
      • Meat and offal
        no withdrawal period
      • Milk
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN07AA01
Authorisation status:
  • Valid
Authorised in:
  • Latvia
Package description:
  • box containing 1 vial of 25 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Labiana Life Sciences S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Labiana Life Sciences S.A.
Responsible authority:
  • Food And Veterinary Service
Authorisation number:
  • V/DCP/21/0039
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0389/001
Concerned member states:
  • Belgium
  • Croatia
  • Cyprus
  • Estonia
  • France
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Portugal
  • Romania

Documents

Summary of Product Characteristics

English (PDF)
Published on: 12/04/2023
Download
Latvian (PDF)
Published on: 23/05/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 23/05/2022

Labelling

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 23/05/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."